Pds biotech announces conference call and webcast for second quarter 2025 financial results

Princeton, n.j., aug. 06, 2025 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the company will host a conference call to report financial results for the quarter ended june 30, 2025 and provide a clinical programs update on wednesday, august 13, 2025 at 8:00 am eastern time.
PDSB Ratings Summary
PDSB Quant Ranking